Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (201-210 of 251) with videos related to

Pageof 26
Sort By:
Dermatology and Therapy|May 10, 2024
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian SettingSarah Alulis, Nicoletta Bernardini, Martina Burlando, et al.
Expert Opinion on Biological Therapy|May 30, 2019
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world studyMatteo Megna, Luisa Di Costanzo, Giuseppe Argenziano, et al.
Life Sciences|September 2, 2020
Immunocytometric analysis of COVID patients: A contribution to personalized therapy?Sara Cacciapuoti, Annunziata De Rosa, Monica Gelzo, et al.
Therapeutic Advances in Gastroenterology|March 5, 2025
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialistsOlga Maria Nardone, Giulio Calabrese, Alessia La Mantia, et al.
Journal of Clinical Medicine|May 11, 2024
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter StudyMatteo Megna, Anna Balato, Stefano Caccavale, et al.
Drugs in Context|September 12, 2024
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVENicoletta Bernardini, Nevena Skroza, Laura Atzori, et al.
Expert Review of Clinical Immunology|June 19, 2025
IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategiesFrancesco Caso, Anella Saviano, Noemi Marigliano, et al.
Dermatology Practical & Conceptual|December 9, 2024
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective StudyLuigi Gargiulo, Luciano Ibba, Alessandra Narcisi, et al.
Vaccines|April 28, 2023
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
The Journal of Dermatological Treatment|January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Pageof 26

Showing results (201-210 of 251) with videos related to

Sort By:
Pageof 26
Dermatology and Therapy|May 10, 2024
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian SettingSarah Alulis, Nicoletta Bernardini, Martina Burlando, et al.
Expert Opinion on Biological Therapy|May 30, 2019
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world studyMatteo Megna, Luisa Di Costanzo, Giuseppe Argenziano, et al.
Life Sciences|September 2, 2020
Immunocytometric analysis of COVID patients: A contribution to personalized therapy?Sara Cacciapuoti, Annunziata De Rosa, Monica Gelzo, et al.
Therapeutic Advances in Gastroenterology|March 5, 2025
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialistsOlga Maria Nardone, Giulio Calabrese, Alessia La Mantia, et al.
Journal of Clinical Medicine|May 11, 2024
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter StudyMatteo Megna, Anna Balato, Stefano Caccavale, et al.
Drugs in Context|September 12, 2024
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVENicoletta Bernardini, Nevena Skroza, Laura Atzori, et al.
Expert Review of Clinical Immunology|June 19, 2025
IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategiesFrancesco Caso, Anella Saviano, Noemi Marigliano, et al.
Dermatology Practical & Conceptual|December 9, 2024
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective StudyLuigi Gargiulo, Luciano Ibba, Alessandra Narcisi, et al.
Vaccines|April 28, 2023
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
The Journal of Dermatological Treatment|January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Pageof 26